Teladoc Health Raises FY2026 GAAP EPS Guidance from $(1.05)-$(0.75) to $(1.00)-$(0.75) vs $(0.92) Est; Lowers FY2026 Sales Guidance from $2.481B-$2.576B to $2.362B-$2.447B vs $2.508B Est

8-K filing — Teladoc Health, Inc. (TDOC)

Filed: 2026-08-03 AccNo: 0001477449-26-000040 Size: 192 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Citigroup Maintains Neutral on Teladoc Health, Lowers Price Target to $7.5

Citigroup analyst Daniel Grosslight maintains Teladoc Health (NYSE:TDOC) with a Neutral and lowers the price target from $11 to $7.5.

Teladoc Health shares are trading lower after Canaccord Genuity and Evercore ISI Group lowered their respective price targets on the stock.

Stock Market Midday, July 30: Microsoft Soars 15%, Boosting Tech Stocks

Markets recovered from yesterday's losses with the Nasdaq up 2.42% as technology stocks rallied. Microsoft surged 15.5% following strong earnings results, boosting investor confidence in AI spending. However, GDP growth slowed to 1.5% in Q2, below expectations, signaling underlying economic uncertainty despite the market rebound.